These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17925883)

  • 61. An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.
    Gau SS; Shen HY; Soong WT; Gau CS
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):441-55. PubMed ID: 16958569
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
    Lewis H; Lewis J
    Atten Defic Hyperact Disord; 2012 Mar; 4(1):37-9. PubMed ID: 22311620
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Successful desensitization of methylphenidate-induced rash.
    Confino-Cohen R; Goldberg A
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):703-5. PubMed ID: 16190802
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Time course and predictors of health-related quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder treated with the methylphenidate transdermal system.
    Frazier TW; Weiss M; Hodgkins P; Manos MJ; Landgraf JM; Gibbins C
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):355-64. PubMed ID: 20973706
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MethyPatch Noven.
    Sane N; McGough JJ
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1222-4. PubMed ID: 12211419
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study.
    Bron TI; Bijlenga D; Kasander MV; Spuijbroek AT; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):542-54. PubMed ID: 22809706
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting.
    Silva R; Muniz R; Pestreich LK; Brams M; Childress A; Lopez FA
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):637-54. PubMed ID: 16190795
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.
    Wigal SB; Gupta S; Heverin E; Starr HL
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):255-63. PubMed ID: 21663428
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder.
    Mick E; McGough JJ; Middleton FA; Neale B; Faraone SV
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):466-72. PubMed ID: 21130132
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 71. Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder.
    Setyawan J; Yang H; Cheng D; Cai X; Signorovitch J; Xie J; Erder MH
    Value Health; 2015 Sep; 18(6):824-31. PubMed ID: 26409610
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Brief psychosis induced by methylphenidate in a child with attention deficit disorder: a case report and literature review.
    Martínez-Aguayo JC; Arancibia M; Meza-Concha N; Bustamante C; Pérez-Bracchiglione J; Madrid E
    Medwave; 2017 Jun; 17(5):e6980. PubMed ID: 28665917
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is There an Effect of Methylphenidate on Thrombocytopenia?
    Ercan ES; Inci SB; Ipci M
    J Clin Psychopharmacol; 2017 Jun; 37(3):374. PubMed ID: 28301399
    [No Abstract]   [Full Text] [Related]  

  • 74. Desensitization to methylphenidate--the relevance of continued drug intake for a successful outcome.
    Rodrigues J; Botelho C; Cadinha S; Castel-Branco MG
    Allergol Immunopathol (Madr); 2008; 36(5):303-5. PubMed ID: 19080803
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations.
    Bell GH; Novak AJ; Griffin WC; Patrick KS
    J Pharm Sci; 2011 Jul; 100(7):2966-78. PubMed ID: 21240977
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nasal Bleeding Probably Associated with Methylphenidate.
    Avcil S
    J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):924-925. PubMed ID: 29131668
    [No Abstract]   [Full Text] [Related]  

  • 77. Immediate-Release Methylphenidate-Associated Recurrent Nasal Bleeding in Siblings.
    Chandradasa M; Rathnayake LC
    J Clin Psychopharmacol; 2019; 39(3):284-285. PubMed ID: 30932948
    [No Abstract]   [Full Text] [Related]  

  • 78. From the Editor-in-Chief's Desk.
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):167. PubMed ID: 30946620
    [No Abstract]   [Full Text] [Related]  

  • 79. An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations.
    Shellenberg TP; Stoops WW; Lile JA; Rush CR
    Expert Rev Clin Pharmacol; 2020 Aug; 13(8):825-833. PubMed ID: 32715789
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Methylphenidate toxicity after Roux-en-Y gastric bypass.
    Ludvigsson M; Haenni A
    Surg Obes Relat Dis; 2016 Jun; 12(5):e55-e57. PubMed ID: 27317601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.